AMI Organics Ltd.
Snapshot View

910.20 +5.50 ▲0.6%

27 September 2022, 10:37:00 AM
Volume: 5,581

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.amiorganics.com
Market Cap 3,296.46 Cr.
Enterprise Value(EV) 3,197.75 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 20.06 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 45.11 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 145.59 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.21 Calculated using Price: 904.70
Dividend Yield 0.33 Period Ending 2022-03
No. of Shares Subscribed 3.64 Cr. 36,437,062 Shares
FaceValue 10
Company Profile
The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.61%
1 Week
-14.28%
1 Month
-8.17%
3 Month
+3.26%
6 Month
+3.00%
1 Year
-27.48%
2 Year
5 Year
10 Year
7 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 46.43 36.44 39.03 33.73 28.31 39.63 21.28
Return on Capital Employed (%) 35.54 35.91 38.24 33.80 26.25 33.01 24.05
Return on Assets (%) 13.87 12.04 13.99 12.64 12.34 16.74 13.42

Balance Sheet View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 27 39 58 82 112 167 522
Non Curr. Liab. 15 15 33 25 25 80 7
Curr. Liab. 49 55 65 106 95 166 129
Minority Int.
Equity & Liab. 91 109 155 213 232 413 659
Non Curr. Assets 25 42 66 89 111 191 223
Curr. Assets 66 66 87 124 121 216 429
Misc. Exp. not W/O 0 0 2 6 7
Total Assets 91 109 155 213 232 413 659

Profit Loss View Details >>

Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 154 160 188 239 240 341 520 538
Other Income 3 0 3 0 3 1 3 2
Total Income 157 160 191 239 242 342 523 540
Total Expenditure -136 -137 -158 -196 -199 -260 -415 -432
PBIDT 21 23 33 42 44 82 108 108
Interest -3 -3 -3 -5 -6 -6 -6 -4
Depreciation -1 -1 -2 -3 -4 -4 -10 -11
Taxation -5 -7 -10 -12 -7 -18 -20 -21
Exceptional Items
PAT 13 12 19 23 27 54 72 73
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 13 12 19 23 27 54 72 73
Adjusted EPS 84 80 123 22 26 6 20 20

Cash Flow View Details >>

Particulars 7 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 10 29 8 15 27 28 -9
Cash Fr. Inv. -14 -19 -25 -21 -24 -101 -124
Cash Fr. Finan. 4 -7 15 6 0 72 140
Net Change 0 3 -2 0 3 -1 8
Cash & Cash Eqvt 0 3 1 0 4 3 10

Shareholding Pattern View Details >>

9 Qtrs 2013-03 (%) 2014-09 (%) 2015-09 (%) 2016-08 (%) 2018-05 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 0.00 0.00 100.00 98.33 81.00 41.05 41.05 41.05 41.05
Public 100.00 100.00 0.00 1.67 19.00 58.95 58.95 58.95 58.95
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 23 Sep 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the Regulation 30 we wish to inform you that the officials of Company held Institutional Investors/Analysts meet as per the details attached.
Thu, 22 Sep 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the Regulation 30 we wish to inform you that the officials of Company held an Institutional Investor/Analyst meet as per the details attached.
Wed, 21 Sep 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the Regulation 30 we wish to inform you that the officials of Company held Institutional Investors/Analysts meet as per the details attached.

Technical Scans View Details >>

Mon, 26 Sep 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 903.40 +0.7%
Divi's Laboratories Ltd. 97,676.51 3,655.10 -0.4%
Cipla Ltd. 85,998.13 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. 51,200.03 1,521.00 +0.5%
Max Healthcare Institute Ltd. 40,653.72 411.85 -1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-06 34.59 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 411.85 -1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-06 4.00 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 411.85 -1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 411.85 -1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.85 -1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.85 -1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 411.85 -1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 903.40 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,655.10 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,084.90 +1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,160.55 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,263.00 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.00 +0.5%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 411.85 -1.3%

FAQ's On AMI Organics Ltd.

What is AMI Organics share price?

Can I buy AMI Organics shares now?

What is the Dividend Yield of AMI Organics?

What is the Market Cap of AMI Organics?

What are the key metrics to analyse AMI Organics?

What is the 52 Week High and Low of AMI Organics?

What is the trend of AMI Organics share price?